Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SP Accure Labs is an India-based pharmaceutical company specializing in the development and manufacture of high-potency oncology products. The company operates a sophisticated manufacturing facility in Hyderabad that is dedicated to cytotoxic formulations, including oral solids and injectables such as liquid and lyophilized vials. SP Accure Labs serves as a contract development and manufacturing organization (CDMO) while also maintaining its own portfolio of generic anti-cancer medications. Their operations are designed to comply with international regulatory standards, including WHO-GMP and EU-GMP, to support global supply chains. The company focuses on providing cost-effective therapeutic solutions for various cancers, including lung, breast, and hematological malignancies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SP Accure Labs.